Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Sandra Dragicevic

9PUBLICATIONS

25CO-AUTHORS

Predictive and prognostic markersCancer geneticsBiomaterialsCardiology (incl. cardiovascular diseases)Medical infection agents (incl. prions)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Feb 27, 2026

Expression Profiles and Biomarker Potential of Long Non-Coding RNAs H19, NEAT1, MALAT1 and HOTAIR in Locally Advanced Rectal Cancer Patients.

Katarina Eric, Jovana Rosic Stojkovic, Marko Miladinov

|Feb 20, 2026

<i>KRAS</i>, <i>NRAS</i> and <i>BRAF</i> Mutational Landscape in Serbian Early-Onset Colorectal Cancer Patients.

Jovana Despotović, Neda Nikolić, Tamara Babic

|Jul 29, 2025

Transcript PHF19-207 May Be a Long Non-Coding RNA with Tumor-Promoting Role in Colon Cancer.

Dunja Pavlovic, Tamara Babic, Sofija Ignjatovic

|Jun 26, 2025

Transcript PHF19-207 as a Potential Biomarker for Colon Cancer Diagnosis and Screening.

Stefan Kmezic, Sandra Dragicevic, Tamara Babic

|May 07, 2025

Diagnostic Potential of CD44, CD133, and VDR in Epithelial Ovarian Tumors: Association with Histopathology Parameters.

Ljubiša Jovanović, Branka Šošić-Jurjević, Anđa Ćirković

|Jul 27, 2024

Markers of Epithelial-Mesenchymal Transition and Mucinous Histology Are Significant Predictors of Disease Severity and Tumor Characteristics in Early-Onset Colorectal Cancer.

Aleksandra Djikic Rom, Sandra Dragicevic, Radmila Jankovic

Pageof 2

Frequent Collaborators

7 joint publications

Aleksandra Nikolic

2 joint publications

Jovana Rosic Stojkovic

1 joint publications

Bojan Stopic

1 joint publications

Branislava Medic-Brkic

1 joint publications

Nada Dimkovic

1 joint publications

Jelena Dinic

1 joint publications

Sanja Jeremic

1 joint publications

Bojana Banovic Djeri

1 joint publications

Aleksandra Djikic Rom

1 joint publications

Radmila Jankovic

Frequent Collaborators

7 joint publications

Aleksandra Nikolic

2 joint publications

Jovana Rosic Stojkovic

1 joint publications

Bojan Stopic

1 joint publications

Branislava Medic-Brkic

Top Related Videos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on : Dec 13, 2018

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on : Jul 17, 2019

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on : May 30, 2025

See more related videos

Top Related Videos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on : Dec 13, 2018

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on : Jul 17, 2019

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on : May 30, 2025

See more related videos